Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 11:05 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2257–2280 of 21,996 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Heart Arrest, Implantable Defibrillator User, Physical Activity
Interventions: E-ICD Intervention; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Hypoxia-Ischemia, Brain, Heart Arrest, Status Epilepticus, Refractory Status Epilepticus, Seizures, Anoxic-Ischemic Encephalopathy, Anoxia-Ischemia, Cerebral
Interventions: Burst Suppression EEG Target Intravenous Anesthesia, Seizure Suppression EEG Target Intravenous Anesthesia; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pulmonary Regurgitation
Interventions: Transcatheter pulmonary valve implantation (TPVI), VenusP-ValveTM System; Device
Lead sponsor: Venus MedTech (HangZhou) Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2034
U.S. locations: 1
States / cities: Irvine, California

Conditions: Esophageal Cancer, Oesophageal Cancer, GastroEsophageal Cancer
Interventions: Induction Chemotherapy (modified FLOT or modified FOLFOX-6), Chemotherapy, Conventional Radiation, Pulsed Low-Dose-Rate (PLDR) Radiation, Surgery; Drug · Radiation · Procedure
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Suicidal Ideation, Suicidal Behavior
Interventions: Integrated skills and safety planning app; Other
Lead sponsor: University of Washington; Other
Eligibility: 13 Years to 21 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Posttraumatic Stress Disorder (PTSD), Intrinsic and Novelty-related Sensory Cortical (SC) Disinhibition
Interventions: Alternating Current Stimulation (tACS), Sham for Transcranial Alternating Current Stimulation (tACS), Transcranial Random Noise stimulation (tRNS); Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 50 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Spinal Cord Injuries
Interventions: Electrophysiology assessment - corticospinal tract, Electrophysiology assessment - reticulospinal tract, Electrophysiology assessment - spinal motoneuron, Activity-based training, Transcutaneous spinal cord stimulation; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 16 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Peripheral Arterial Disease
Interventions: Walking assessment, QOL Survey, Ankle pressure at rest and after stress, Muscle Oxygen, Serum MitoQ Level, Needle Biopsy; Diagnostic Test · Other · Procedure
Lead sponsor: University of Nebraska; Other
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Cardiogenic Shock
Interventions: IABP; Device
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Colo-rectal Cancer
Interventions: Not listed
Lead sponsor: Natera, Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 25,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2033
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Fibroid Uterus
Interventions: Methadone; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Lichen Plano-Pilaris
Interventions: Nemolizumab; Drug
Lead sponsor: The Skin Center Dermatology Group; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New City, New York

Conditions: fMRI
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 7 Years to 35 Years
Enrollment: 480 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma, Oligometastatic Breast Carcinoma
Interventions: Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment, Computed Tomography, Cyclin-Dependent Kinase 4 Inhibitor, Cyclin-Dependent Kinase 6 Inhibitor, Echocardiography Test, HER2-targeted Therapy, Hormone Therapy, Magnetic Resonance Imaging, Mammography, Pertuzumab, Positron Emission Tomography, Radiation Boost, Radiation Therapy, Stereotactic Body Radiation Therapy, Stereotactic Radiosurgery, Taxane Compound, Total Mastectomy, Trastuzumab, Trastuzumab Deruxtecan, Trastuzumab Emtansine, Ultrasound Imaging; Procedure · Drug · Biological + 1 more
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 562 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2033
U.S. locations: 59
States / cities: Jonesboro, Arkansas • Derby, Connecticut • Fairfield, Connecticut + 45 more

Conditions: Chronic Kidney Diseases, Pediatric Kidney Disease
Interventions: Empagliflozin 10 MG; Drug
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 12 Years to 25 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Prolactin-Producing Pituitary Tumor
Interventions: Pasireotide, SF-36 and HADS; Drug · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Breast Cancer Female, Psychological Distress
Interventions: Cognitively-Based Compassion Training for Survivors, Cognitively-Based Compassion Training for Dyads, Health Education; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 452 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Gliosis, Child Obesity, Eating
Interventions: Diet modification; Other
Lead sponsor: University of Washington; Other
Eligibility: 9 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Malignant Neoplasm
Interventions: Biospecimen Collection, Questionnaire Administration; Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: Not listed
Enrollment: 999,999 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 2033
U.S. locations: 35
States / cities: Phoenix, Arizona • Concord, California • Duarte, California + 29 more

Conditions: Metastatic Prostate Cancer
Interventions: Provider-level and patient education at end of study, Provider-level and patient-level; Other
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older · Male only
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Subconcussive Head Impact, Omega-3 Fatty Acids
Interventions: Omega-3 Fatty Acids (EPA plus DHA), Organic soybean oil, Soccer Heading Model; Dietary Supplement · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Parkinson Disease
Interventions: Non-interventional; Other
Lead sponsor: Parkinson's Foundation; Other
Eligibility: 18 Years and older
Enrollment: 1,000,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2030
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
Interventions: Vedolizumab; Biological
Lead sponsor: Alimentiv Inc.; Other
Eligibility: 18 Years to 80 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 3
States / cities: Los Angeles, California • Charleston, South Carolina • Houston, Texas

Conditions: Anxiety Disorders
Interventions: Adapted Project BRAVE; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Search by objective public record fields.

Effectiveness of Exercise After an ICD

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

VenusP-Valve Pivotal Study (PROTEUS STUDY)

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Integrated Suicide Supports and Safety Planning for Youth

A Neurosensory Account of Anxiety and Stress (Study 1)

Spinal Cord Stimulation and Training

MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology

Physiology of Unloading VA ECMO Trial

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.

Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.

A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

A Study of Pasireotide in People With Prolactinoma

The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project

Building Research for Intervention Development in Gliosis and Eating Habits

Molecular Genetics Studies of Cancer Patients and Their Relatives

Physician- and Patient-based Barriers to NGS Testing

Omega-3 Fatty Acids and Subconcussive Head Impacts

Parkinson's Foundation Surveys

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Cultural Adaptation of a SSI for Youth Anxiety